• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Platelet-activating factor acetylhydrolase in the male reproductive tract: origin and properties.

作者信息

Jarvi K, Langlais J, Gagnon C, Roberts K D

机构信息

Royal Victoria Hospital, Montreal, Quebec, Canada.

出版信息

Int J Androl. 1993 Apr;16(2):121-7. doi: 10.1111/j.1365-2605.1993.tb01164.x.

DOI:10.1111/j.1365-2605.1993.tb01164.x
PMID:8514423
Abstract

The properties and origin of platelet-activating factor acetylhydrolase- (PAF-AH)-like activity in the male reproductive tract were investigated. Seminal plasma (SP) and serum were obtained from normal donors and infertile patients while prostatic fluid (PF), seminal vesicle fluid (SVF) and vas deferens fluid were collected at autopsy. PAF-AH-like activity was found in all fluids tested. The specific activity of the enzyme in SP and PF was twice that of PAF-AH in serum and 15-fold higher than that in SVF and vas deferens fluid. In SP, PAF-AH-like activity was Ca(++)-independent, acid and heat labile, stable to freezing, not inhibited by phosphatidylcholine, but was inhibited by 10 mM disopropylfluorophosphate (DFP) and 13 mM phenylmethylsulfonylfluoride (PMSF). These data indicate that the properties of the enzyme in SP are similar to those reported for PAF-AH in serum. The variation in specific activity of PAF-AH in reproductive tract fluids suggest that there are either activators of PAF-AH in SP or inhibitors in one or several of the other reproductive tract fluids.

摘要

相似文献

1
Platelet-activating factor acetylhydrolase in the male reproductive tract: origin and properties.
Int J Androl. 1993 Apr;16(2):121-7. doi: 10.1111/j.1365-2605.1993.tb01164.x.
2
Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.牛精浆中血小板活化因子乙酰水解酶的部分纯化及定位
J Androl. 1997 Sep-Oct;18(5):540-8.
3
Bovine seminal platelet-activating factor acetylhydrolase: association properties in seminal plasma and with lipoproteins.牛精浆血小板激活因子乙酰水解酶:在精浆中的缔合特性及其与脂蛋白的关系
Biochim Biophys Acta. 1998 Jun 15;1392(2-3):176-84. doi: 10.1016/s0005-2760(98)00037-x.
4
Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.牛精浆中血小板活化因子乙酰水解酶活性
J Androl. 1993 Sep-Oct;14(5):335-9.
5
Platelet-activating factor acetylhydrolase activity in seminal plasma from the bull, stallion, rabbit, and rooster.公牛、种马、兔子和公鸡精液中血小板活化因子乙酰水解酶的活性
Biol Reprod. 1994 Apr;50(4):912-6. doi: 10.1095/biolreprod50.4.912.
6
Platelet-activating factor acetylhydrolase in human seminal plasma.人精浆中的血小板活化因子乙酰水解酶
Fertil Steril. 1992 Jan;57(1):193-8.
7
Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase.来自牛精浆的磷脂酶A2是一种血小板活化因子乙酰水解酶。
Biochem J. 1998 Jan 1;329 ( Pt 1)(Pt 1):41-7. doi: 10.1042/bj3290041.
8
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.人支气管肺泡灌洗中血小板活化因子乙酰水解酶的特性分析
Am J Respir Crit Care Med. 1997 Jul;156(1):94-100. doi: 10.1164/ajrccm.156.1.9608084.
9
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.不稳定型心绞痛患者体内血小板对血小板激活因子(PAF)的体外聚集反应及PAF - 乙酰水解酶活性:c7E3 Fab(阿昔单抗)治疗的影响
Cardiovasc Res. 1999 Jul;43(1):183-91. doi: 10.1016/s0008-6363(99)00078-4.
10
Detection and characterization of 45 kDa platelet activating factor acetylhydrolase in cerebrospinal fluid of children with meningitis.
Arch Pharm Res. 2003 Jul;26(7):554-8. doi: 10.1007/BF02976880.

引用本文的文献

1
Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase.来自牛精浆的磷脂酶A2是一种血小板活化因子乙酰水解酶。
Biochem J. 1998 Jan 1;329 ( Pt 1)(Pt 1):41-7. doi: 10.1042/bj3290041.